Developers


Memantine Wikipedia the free encyclopedia

... acting on the glutamatergic system by blocking NMDA glutamate receptors. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck ...Health: 1,497 Cold Resist: 376 Power: 1,663 Heat Resist: 405 Strength: 156 Poison Resist: 447 Agility: 189 Disease ResistComplete residency management software solution for graduate medical education. Features include duty hour tracking, evaluations, vacation & leave tracking, rotation block ...The GLObal blog directory Search results for: AbixaTop of page Abstract. Many drugs that have been developed to treat neurodegenerative diseases fail to gain approval for clinical use because they are not well tolerated in humans.Namenda is a Alzheimer's disease medication that has been proven effective in helping to safely treat the symptoms of Alzheimer's disease.
Share this post:
  • E-mail this story to a friend!
  • Print this article!
  • Netvibes
  • Digg
  • Reddit
  • del.icio.us
  • blogmarks
  • Facebook
  • description

Paradigm shift in neuroprotection by NMDA receptor blockade Memantine

Top of page Abstract. Neuroprotective drugs tested in clinical trials, particularly those that block N-methyl-D-aspartate-sensitive glutamate receptors , have failed ...1: J Neurochem. 2006 Jun;97:1611-26. The chemical biology of clinically tolerated NMDA receptor antagonists. Chen HS, Lipton SA. Burnham Institute for Medical Research and the ...PubMed is a service of the U.S. National Library of Medicine that includes over 18 million citations from MEDLINE and other life science journals for biomedical articles back to ...
Share this post:
  • E-mail this story to a friend!
  • Print this article!
  • Netvibes
  • Digg
  • Reddit
  • del.icio.us
  • blogmarks
  • Facebook
  • description

Comments

0 | Posted by piestrak, Thu, 01 Jan 1970 13:00:46 -0500

he is like gifts gifts gifts lol

Add a comment


Developers

Build once, run everywhere.

Community

Get involved, get localized.